Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Allergy & Immunology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
AI Models to Personalise Immune Therapies for Patients with Cancer
November 2024
The study aims to customise CIC profiles for patients, providing insights into which stages of the cycle are most relevant for tailored cancer therapies and diagnostics.
Read more
15 Oct 2015
Dr Jim Duthie, Our #EMJExpert, Answers Your Questions for Blue September
In support of Blue September, an annual campaign designed to raise global awareness for male related cancers, we invited world-renowned urologist Dr Jim…
5 Oct 2015
TMIGD1: A Protein; an Immunoglobulin; a Protector of Kidney Cells
TRANSMEMBRANE and immunoglobulin domain-containing 1 (TMIGD1), a previously unknown protein involved in protecting kidney epithelial cells…
25 Sep 2015
European CHMP Adopts Positive Opinion for Gilead’s Single Tablet Regimen Genvoya® (Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide) for the Treatment of HIV
Foster City, CA, September XX, 2015 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP)…
7 Sep 2015
Plans for Universal Flu Vaccine Receive Timely Boost
DREAMS of a universal flu vaccine that is effective against all flu strains are a step closer to becoming a reality thanks to the findings of a new study.
10 Apr 2014
International Coeliac Day 16 May 2014
As part of this year’s International Coeliac Day, AOECS is raising awareness for an improvement in diagnosis rates of coeliac disease.
Loading posts...
« Previous
1
…
16
17
18